comparemela.com
Home
Live Updates
Sanofi goes oral route in Recludix deal to develop tailored I&I drugs : comparemela.com
Sanofi goes oral route in Recludix deal to develop tailored I&I drugs
The Sanofi-Recludix deal is another sign that oral development programs against autoimmune disease targets are enjoying a bit of a moment.
Related Keywords
France
,
French
,
Nancy Whiting
,
Ventyx Biosciences
,
Frank Nestle
,
Eli Lilly
,
Drug Administration
,
Recludix Pharma
,
Dice Therapeutics
,
comparemela.com © 2020. All Rights Reserved.